These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6591983)

  • 1. An improved filtration rate for measuring red cell deformability.
    Sowemimo-Coker SO; Kovacs IB; Turner P; Kirby JD
    Biorheology Suppl; 1984; 1():249-53. PubMed ID: 6591983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood microfiltration methods].
    Marcel GA; George C; Weill D; Catry E
    J Mal Vasc; 1983; 8(3):227-32. PubMed ID: 6631254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte filtrability measurement by the initial flow rate method.
    Hanss M
    Biorheology; 1983; 20(2):199-211. PubMed ID: 6409181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtrability investigations with red blood cell (RBC) suspensions: effects of different blood components and pentoxifylline on RBC flow rate.
    Seiffge D; Kiesewetter H
    Ric Clin Lab; 1981; 11 Suppl 1():117-23. PubMed ID: 7188104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered behaviour of erythrocytes in scleroderma.
    Kovacs IB; Sowemimo-Coker SO; Kirby JD; Turner P
    Clin Sci (Lond); 1983 Nov; 65(5):515-9. PubMed ID: 6617097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filtration pressure and red blood cell deformability: evaluation of a new device: erythrometre.
    Guéguen M; Bidet JM; Durand F; Driss F; Joffre A; Genetet B
    Biorheology Suppl; 1984; 1():261-5. PubMed ID: 6591984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythrocyte filterability in Raynaud's disease].
    Sciannameo F; Francucci M; Cao PG; Marianeschi P; Valentini M; Tockner M; Sassano L; Grasselli A
    Ric Clin Lab; 1983; 13 Suppl 3():475-80. PubMed ID: 6673030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.
    Dowd PM; Kovacs IB; Bland CJ; Kirby JD
    Br Med J (Clin Res Ed); 1981 Aug; 283(6287):350. PubMed ID: 6788326
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of red cell concentration on filtration of blood cell suspensions.
    Schmalzer EA; Skalak R; Usami S; Vayo M; Chien S
    Biorheology; 1983; 20(1):29-40. PubMed ID: 6871424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of erythrocyte deformability by constant flow filtration technique: analysis of factors influencing the initial pressure.
    Chan MT; Catry E; Weill D; Marcel GA; George C
    Biorheology Suppl; 1984; 1():267-70. PubMed ID: 6591985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological improvement of altered red cell deformability.
    Marcel GA
    Ric Clin Lab; 1981; 11 Suppl 1():179-88. PubMed ID: 6821316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deformability of stored normal and sickle haemoglobin erythrocytes.
    Adewuyi JO; Awarun JA
    Afr J Med Med Sci; 1990 Jun; 19(2):115-9. PubMed ID: 2115726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of red blood cell filterability test: influences of pore size, hematocrit level, and flow rate.
    Reinhart WH; Usami S; Schmalzer EA; Lee MM; Chien S
    J Lab Clin Med; 1984 Oct; 104(4):501-16. PubMed ID: 6481214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole increases red cell deformability.
    Sowemimo-Coker SO; Kovacs IB; Pickles H; Hedges A; Turner P
    Br J Clin Pharmacol; 1983 Oct; 16(4):423-5. PubMed ID: 6626435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrometer: a new device for measuring erythrocyte filterability and plasma viscosity.
    Stoltz JF; Duvivier C; Malher E
    Biorheology Suppl; 1984; 1():255-9. PubMed ID: 6434002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell deformability: physiological, clinical and pharmacological aspects.
    Marcel GA
    J Med; 1979; 10(5):409-16. PubMed ID: 231079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of erythrocytes transit times through a 5 mu "nuclepore" filter.
    Koutsouris D; Hanss M; Skalak R
    Biorheology; 1983; 20(6):779-87. PubMed ID: 6661528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome.
    Belch JJ; McLaren M; Anderson J; Lowe GD; Sturrock RD; Capell HA; Forbes CD; Mikhailidis DP; Jeremy JY; Dandona P
    Prostaglandins Leukot Med; 1985 Jun; 18(3):401-2. PubMed ID: 3895252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.